Trial intelligence / Profile preview

Guaipazet maleate injection for acute ischemic stroke

CTR20160762Phase 4Active

Sponsor
Qilu Pharmaceutical
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cinepazide in brain infarction, ischemic stroke, sponsored by Qilu Pharmaceutical. Started Oct 2016; status: active.

02

Drugs

cinepazide
03

Conditions

brain infarctionischemic stroke

Beyond the preview

Go deeper on CTR20160762.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160762.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call